Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04666688
What this trial is testing

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorPancreatic Cancer+3 more
PureTech 44
Testing effectiveness (Phase 2)Ended earlyNCT02173990
What this trial is testing

Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).

Who this might be right for
Metastatic Colorectal Cancer
Centre Oscar Lambret 40
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Testing effectiveness (Phase 2)Study completedNCT01117428
What this trial is testing

Sym004 in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic Colorectal Cancer
Symphogen A/S 111
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Not applicableUnknownNCT05818267
What this trial is testing

Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Wei Zhang 30
Testing effectiveness (Phase 2)Study completedNCT01161316
What this trial is testing

Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 194
Early research (Phase 1)UnknownNCT05031949
What this trial is testing

Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Combinational ImmunotherapyHepatocellular Carcinoma Non-ResectableHyperbaric Oxygen Therapy
Zhang Bi Xiang, MD 20
Testing effectiveness (Phase 2)Study completedNCT00521404
What this trial is testing

Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 65
Testing effectiveness (Phase 2)Ended earlyNCT00493857
What this trial is testing

Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
YM BioSciences 100
Early research (Phase 1)Ended earlyNCT01134601
What this trial is testing

A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum

Who this might be right for
Non-Metastatic Adenocarcinoma of the Rectum
National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT01270698
What this trial is testing

Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Gilead Sciences 26
Early research (Phase 1)Ended earlyNCT04044430
What this trial is testing

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+25 more
University of California, San Francisco 2
Early research (Phase 1)Study completedNCT00026364
What this trial is testing

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 22
Not applicableEnded earlyNCT02614157
What this trial is testing

Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer

Who this might be right for
Rectal Cancer
West China Hospital 51
Not applicableStudy completedNCT04143230
What this trial is testing

Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool

Who this might be right for
Locally Advanced CancerMetastatic CancerChronic Respiratory Failure+3 more
A.O.U. Città della Salute e della Scienza 660
Early research (Phase 1)UnknownNCT04612504
What this trial is testing

SynOV1.1 Intratumoral Injection Study

Who this might be right for
Hepatocellular Carcinoma
Beijing Syngentech Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT01348412
What this trial is testing

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Who this might be right for
Colorectal CancerLiver Metastases
Centre Georges Francois Leclerc 31
Testing effectiveness (Phase 2)UnknownNCT01249521
What this trial is testing

Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Austin Health 40
Next Page